April 7 (Reuters) - Anatara Lifesciences Ltd (ANR) :
- CONTINUE TO ADVANCE LICENSING TALKS WITH POTENTIAL ANIMAL HEALTH PARTNERS FOR CORE ANIMAL ASSET, DETACH
- AT CURRENT TIME, ANTICIPATES DELAY, TO SECOND HALF OF 2020, FOR COMMENCEMENT OF ITS CLINICAL TRIAL IN IRRITABLE BOWEL SYNDROME
- DO NOT ANTICIPATE A MATERIAL DELAY OF MEETING PARTNERING MILESTONE FOR CORE ANIMAL ASSET DUE TO COVID-19
- AIM OF MEETING PARTNERING MILESTONE OF END Q2 FOR CORE ANIMAL ASSET, DETACH
News: ANR Anatara Lifesciences Says Co Continues Licensing Talks With Potential Animal Health...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.1¢ |
Change
-0.002(15.4%) |
Mkt cap ! $2.349M | |||
| Open | High | Low | Value | Volume |
| 1.3¢ | 1.3¢ | 1.1¢ | $41.30K | 3.398M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 2003147 | 1.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.3¢ | 1354471 | 3 |
View Market Depth
| Last trade - 16.10pm 09/09/2025 (20 minute delay) ? |
| ANR (ASX) Chart |